Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306%

Published 03/10/2022, 13:48
Updated 03/10/2022, 14:41
© Reuters. Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306%

  • Wells Fargo (NYSE:WFC) cut the price target on The Coca-Cola Company (NYSE: NYSE:KO) from $72 to $66. Wells Fargo analyst Chris Carey maintained an Overweight rating on the stock. Coca-Cola shares rose 0.3% to $56.20 in pre-market trading.
  • Chardan Capital boosted the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $62 to $65. Chardan Capital analyst Geulah Livshits maintained the stock with a Buy. Rocket Pharmaceuticals shares rose 1.8% to $16.25 in pre-market trading.
  • Raymond James cut the price target on Rent-A-Center, Inc. (NASDAQ: RCII) from $35 to $28. Rent-A-Center shares gained 1.9% to $17.50 in pre-market trading.
  • Piper Sandler raised the price target for Pinterest, Inc. (NYSE: NYSE:PINS) from $22 to $23. Pinterest shares rose 0.9% to $23.50 in pre-market trading.
  • Wells Fargo cut the price target for Church & Dwight Co., Inc. (NYSE: CHD) from $90 to $82. Church & Dwight shares fell 2% to close at $71.44 on Friday.
  • JMP Securities raised the price target on Cytokinetics, Incorporated (NASDAQ: CYTK) from $53 to $82. Cytokinetics shares fell 1% to close at $48.45 on Friday.
  • Mizuho slashed the price target on Consolidated Edison, Inc. (NYSE: ED) from $99 to $91. Consolidated Edison shares fell 2.2% to close at $85.76 on Friday.
Nike NKE

Don’t forget to check out our premarket coverage here .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.